We examined the clinical data of 77 patients with PCa and lymph node metastasis (LN+) and then evaluated the levels of IL-17A and IL-17RA expression in the prostate and LN+. The gene discussed is IL17RA; the disease is metastatic malignant neoplasm in the lymph nodes.